Your browser doesn't support javascript.
loading
Measuring coping in multiple sclerosis: The Coping Index-MS.
Young, Carolyn A; Mills, Roger J; Langdon, Dawn; Rog, David J; Sharrack, Basil; Kalra, Seema; Majeed, Tahir; Footit, David; Harrower, Tim; Nicholas, Richard S; Ford, Helen L; Woolmore, John; Johnstone, Clare; Thorpe, John; Paling, David; Ellis, Cathy; Hanneman, C Oliver; Tennant, Alan.
Afiliação
  • Young CA; The Walton Centre NHS Foundation Trust, Liverpool, UK/University of Liverpool, Liverpool, UK.
  • Mills RJ; The Walton Centre NHS Foundation Trust, Liverpool, UK/University of Liverpool, Liverpool, UK.
  • Langdon D; Royal Holloway, University of London, Egham, UK.
  • Rog DJ; Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK.
  • Sharrack B; Academic Department of Neurology, The University of Sheffield, Sheffield, UK.
  • Kalra S; University Hospital of North Midlands NHS Trust, Stoke-on-Trent, UK.
  • Majeed T; Lancashire Teaching Hospitals, Preston, UK.
  • Footit D; Cumbria Partnership NHS Foundation Trust, Carlisle, UK.
  • Harrower T; University of Exeter, Exeter, UK.
  • Nicholas RS; Charing Cross Hospital, London, UK.
  • Ford HL; Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Woolmore J; Queen Elizabeth Hospital, Birmingham, UK.
  • Johnstone C; York and Scarborough Teaching Hospitals NHS Foundation Trust, York, UK.
  • Thorpe J; Peterborough City Hospital, Peterborough, UK.
  • Paling D; Royal Hallamshire Hospital, Sheffield, UK.
  • Ellis C; Dartford & Gravesham NHS Trust, Dartford, UK.
  • Hanneman CO; University of Plymouth, Plymouth, UK.
  • Tennant A; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
Mult Scler ; 28(14): 2274-2284, 2022 12.
Article em En | MEDLINE | ID: mdl-36000480
ABSTRACT

BACKGROUND:

Coping in multiple sclerosis (MS) refers to cognitive and behavioural efforts to manage stresses imposed by the illness. Existing generic and disease-specific coping scales do not meet modern guidelines for scale development and cannot produce interval-level metrics to allow for change scores.

OBJECTIVE:

The main aim of this study was to develop a brief patient-reported outcome measure for coping in MS, capable of interval-level measurement.

METHODS:

Qualitative work in 43 people with MS leads to a draft scale which was administered to 5747 participants, with longitudinal collection in 2290. A calibration sample of 1000 subjects split into development and validation sets was used to generate three scales consistent with Rasch model expectations.

RESULTS:

The total Coping Index-MS (CI-MS-T), CI-MS-Internal (CI-MS-I) and CI-MS-External (CI-MS-E) cover total, internal and externally focused coping. All three scales are capable of interval-level measurement. Trajectory analysis of 9000 questionnaires showed two trajectories in CI-MS-T Group 1 showed a low level of coping with slight decline over 40 months, while Group 2 had a better and stable level of coping due to improving CI-MS-I which compensated for the deteriorating CI-MS-E over time. CI-MS-T < 30 identified group membership at baseline.

CONCLUSION:

The CI-MS-T, CI-MS-I and CI-MS-E, comprising 20 items, provide interval-level measurement and are free-for-use in not-for-profit settings.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: Mult Scler Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido